WHO Classifies GC Cell’s Immuncell-LC as an ‘Anti-Tumor Cell and Gene Therapy’

조선일보

Lean Right

Factuality

Ownership

GC Cell's immunotherapy drug, 'ImmuneCell-LC,' will be listed as an anticancer cell and gene therapy under the World Health Organization (WHO) Drug Classification System. As the product, previously classified as an immunostimulant, is reclassified as an anticancer treatment within the international pharmaceutical standard system, its utility is expected to increase during the process of entering overseas markets. On the 9th, GC Cell announced th…